Cipvision Olpatprime 0.1%

If you are pregnant, planning pregnancy, or think you may be pregnant, consult your doctor before using Olopatadine Hydrochloride. Your healthcare professional can evaluate your condition and determine whether the expected benefits of treatment outweigh any potential risks during pregnancy.

If you are breastfeeding, consult your doctor before using Olopatadine Hydrochloride eye drops. Although ophthalmic administration generally results in limited systemic exposure, your healthcare professional can assess your individual situation and advise whether continued treatment is appropriate while breastfeeding.

Olopatadine Hydrochloride eye drops may cause temporary blurred vision or other visual disturbances immediately after application in some patients. Avoid driving, cycling, operating machinery, or performing activities requiring clear vision until your eyesight has returned to normal.

Tell your doctor if you have kidney disease or reduced kidney function before using Olopatadine Hydrochloride. Because this is an ophthalmic medicine, systemic exposure is generally limited, but your healthcare professional can determine whether any additional precautions are required.

Inform your doctor if you have liver disease or impaired liver function before using Olopatadine Hydrochloride. Your healthcare professional can review your medical history and other medicines to determine whether this eye treatment is suitable and whether any precautions are necessary.